APA

Pietrantonio F., Biondani P., Milione M., Melotti F., Bertarelli G., Perrone F., de Braud F., Mariani L., Fanetti G., Cortinovis D. & Di Bartolomeo M. (20140319). Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Chicago

Pietrantonio F, Biondani P, Milione M, Melotti F, Bertarelli G, Perrone F, de Braud F, Mariani L, Fanetti G, Cortinovis D and Di Bartolomeo M. 20140319. Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Harvard

Pietrantonio F., Biondani P., Milione M., Melotti F., Bertarelli G., Perrone F., de Braud F., Mariani L., Fanetti G., Cortinovis D. and Di Bartolomeo M. (20140319). Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

MLA

Pietrantonio F, Biondani P, Milione M, Melotti F, Bertarelli G, Perrone F, de Braud F, Mariani L, Fanetti G, Cortinovis D and Di Bartolomeo M. Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20140319.